Nothing Special   »   [go: up one dir, main page]

NL194914B - 4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat. - Google Patents

4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat.

Info

Publication number
NL194914B
NL194914B NL8802464A NL8802464A NL194914B NL 194914 B NL194914 B NL 194914B NL 8802464 A NL8802464 A NL 8802464A NL 8802464 A NL8802464 A NL 8802464A NL 194914 B NL194914 B NL 194914B
Authority
NL
Netherlands
Prior art keywords
benzopyran
salt
pharmaceutical composition
composition containing
active substance
Prior art date
Application number
NL8802464A
Other languages
English (en)
Other versions
NL194914C (nl
NL8802464A (nl
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NL8802464A publication Critical patent/NL8802464A/nl
Publication of NL194914B publication Critical patent/NL194914B/nl
Application granted granted Critical
Publication of NL194914C publication Critical patent/NL194914C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/54—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 substituted in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
NL8802464A 1987-10-08 1988-10-07 4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat. NL194914C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP25425187 1987-10-08
JP25425187 1987-10-08
JP11999088 1988-05-17
JP11999088 1988-05-17
JP63250811A JPH0753725B2 (ja) 1987-10-08 1988-10-06 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
JP25081188 1988-10-06

Publications (3)

Publication Number Publication Date
NL8802464A NL8802464A (nl) 1989-05-01
NL194914B true NL194914B (nl) 2003-03-03
NL194914C NL194914C (nl) 2003-07-04

Family

ID=27313952

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8802464A NL194914C (nl) 1987-10-08 1988-10-07 4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat.

Country Status (16)

Country Link
US (1) US4954518A (nl)
JP (1) JPH0753725B2 (nl)
KR (1) KR910007970B1 (nl)
AT (1) AT397088B (nl)
AU (1) AU605363B2 (nl)
BE (1) BE1002226A5 (nl)
CA (1) CA1320959C (nl)
CH (1) CH679397A5 (nl)
DE (1) DE3834204A1 (nl)
ES (8) ES2013801A6 (nl)
FI (1) FI98460C (nl)
FR (1) FR2621585B1 (nl)
GB (1) GB2210879B (nl)
IT (1) IT1235048B (nl)
NL (1) NL194914C (nl)
SE (1) SE468595B (nl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
EP0549729B1 (en) * 1990-09-07 1997-12-17 Schering Corporation Antiviral compounds and antihypertensive compounds
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
CA2159192C (en) * 1993-04-09 2006-07-25 Keiichi Tanaka Immunomodulator cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
NZ504045A (en) 1997-11-19 2001-06-29 Kowa Co Pyridazine derivatives with inhibitory action against interleukin-1-beta production
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
US6649645B1 (en) * 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
JP2001055331A (ja) * 1999-06-11 2001-02-27 Toyama Chem Co Ltd アトピー性皮膚炎治療剤
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
GB0119863D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP3972663B2 (ja) * 2002-01-22 2007-09-05 松下電器産業株式会社 高周波信号受信装置
US7049313B2 (en) * 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
MXPA04010240A (es) * 2002-04-17 2005-06-08 Cytokinetics Inc Compuestos, composiciones y metodos.
CA2485681C (en) * 2002-05-24 2012-10-16 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US6949538B2 (en) * 2002-07-17 2005-09-27 Cytokinetics, Inc. Compounds, compositions, and methods
EP1554265A4 (en) * 2002-09-13 2008-05-07 Cytokinetics Inc COMPOSITIONS, COMPOSITIONS AND M THODES
DE60314175T2 (de) * 2002-11-18 2008-01-24 Chemocentryx Inc., Mountain View Arylsulfonamide
US7420055B2 (en) * 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7227035B2 (en) * 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US7741519B2 (en) * 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
DE10256182A1 (de) * 2002-12-02 2004-06-24 Merck Patent Gmbh 2-Oxadiazolchromonderivate
WO2004080991A1 (ja) * 2003-03-14 2004-09-23 Toyama Chemical Co., Ltd. N-[3-(ホルミルアミノ)-4-オキソ-6-フェノキシ-4h-クロメン-7-イル]メタンスルホンアミドの新規な結晶
CA2518227A1 (en) * 2003-03-18 2004-09-30 Kowa Co., Ltd Water-soluble phenylpyridazine derivative and medicine containing the same
CN100387231C (zh) * 2003-03-24 2008-05-14 天津药物研究院 一种制备古拉替莫固体制剂的工艺及其固体制剂
ATE461193T1 (de) * 2003-08-13 2010-04-15 Kudos Pharm Ltd Aminopyrone und ihre verwendung als atm inhibitoren
EP1670456A2 (en) * 2003-10-06 2006-06-21 Cytokinetics, Inc. Compounds, compositions and methods
KR20070059156A (ko) * 2004-09-20 2007-06-11 쿠도스 파마슈티칼스 리미티드 Ｄｎａ－ｐｋ 억제제
TW200638938A (en) * 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR053358A1 (es) * 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
UY29774A1 (es) * 2005-08-31 2007-03-30 Kudos Pharm Ltd Inhibidor de atm
CN101885718B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
CN101885717B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
CN101891726B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
JP4788955B2 (ja) * 2006-01-13 2011-10-05 住友金属工業株式会社 鉄道車両における操舵用アクチュエータの制御方法
AU2006233256B2 (en) * 2006-10-30 2012-01-19 Armaron Bio Pty Ltd Improved flavonols
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
UY31232A1 (es) * 2007-07-19 2009-03-02 Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
JP5828235B2 (ja) 2011-07-21 2015-12-02 新日鐵住金株式会社 鉄道車両用操舵台車
SMT201700606T1 (it) 2013-07-18 2018-01-11 Toyama Chemical Co Ltd Agente terapeutico per malattia basato sull'effetto di inibizione del fattore inibitore della migrazione dei macrofagi
CN106986797B (zh) * 2017-04-24 2018-09-28 常州佳德医药科技有限公司 N-(2-(4-乙酰苯氧基)-5-甲氧基苯基)甲磺酰胺及其制备方法
CN107021891A (zh) * 2017-04-24 2017-08-08 常州佳德医药科技有限公司 一种艾拉莫德中间体的制备方法
CN111170914B (zh) * 2018-11-09 2021-12-21 成都大学 硒/硫化磺酰芳胺类化合物及其硒/硫化方法
CN109705000A (zh) * 2019-02-26 2019-05-03 南京红杉生物科技有限公司 艾拉莫德中间体及其合成方法
CN115667212A (zh) * 2020-05-29 2023-01-31 富士胶片富山化学株式会社 高纯度的n-(5-甲氧基-2-苯氧基苯基)甲磺酰胺及其制造方法
CN113968838B (zh) * 2020-07-25 2024-04-02 华创合成制药股份有限公司 一种硫代苯并吡喃类化合物及其在类风湿性关节炎治疗中的应用
CN113968836A (zh) * 2020-07-25 2022-01-25 华创合成制药股份有限公司 一种苯并吡喃衍生物及其在类风湿性关节炎治疗中的应用
CN114539104A (zh) * 2022-03-09 2022-05-27 常州佳德医药科技有限公司 一种艾拉莫德中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661990A (en) * 1970-04-13 1972-05-09 Riker Laboratories Inc N-alkylsulfonyl benzoylhaloalkylsulfonanilides
US3689523A (en) * 1971-01-04 1972-09-05 Minnesota Mining & Mfg Substituted haloalkanesulfonanilides
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
GB1499323A (en) * 1974-03-22 1978-02-01 Fisons Ltd 6-substituted chromones and chromanones
DE2537204A1 (de) * 1974-08-23 1976-03-04 Fisons Ltd Neue benzopyrane und verfahren zu ihrer herstellung
DE2965279D1 (en) * 1978-07-27 1983-06-01 Schering Ag Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
DE3110009A1 (de) * 1981-03-11 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue benzofuran-derivate, ihre herstellung und verwendung
DE3208079A1 (de) * 1982-03-04 1983-09-08 Schering AG, 1000 Berlin und 4709 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
DE3343331A1 (de) * 1983-11-28 1985-06-05 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von indanyl-derivaten und deren verwendung
US4713393A (en) * 1985-04-25 1987-12-15 Merck & Co., Inc. Phenylpropyl-2,3-dihydrobenzofurans useful as anti-inflammatory agents
PT86407B (pt) * 1986-12-31 1990-11-20 Fujisawa Pharmaceutical Co Processo para a preparacao de novos derivados de alcano-sulfonanilida, e de composicoes farmaceuticas compreendendo os mesmos

Also Published As

Publication number Publication date
SE468595B (sv) 1993-02-15
AU605363B2 (en) 1991-01-10
ES2018112A6 (es) 1991-03-16
IT8848441A0 (it) 1988-10-10
DE3834204C2 (nl) 1992-04-23
FR2621585A1 (fr) 1989-04-14
NL194914C (nl) 2003-07-04
FI884626A (fi) 1989-04-09
AU2348988A (en) 1989-04-13
ES2013801A6 (es) 1990-06-01
SE8803570L (sv) 1989-04-09
ES2017839A6 (es) 1991-03-01
FI98460B (fi) 1997-03-14
BE1002226A5 (fr) 1990-10-23
IT1235048B (it) 1992-06-17
ES2018113A6 (es) 1991-03-16
JPH0249778A (ja) 1990-02-20
SE8803570D0 (sv) 1988-10-07
US4954518A (en) 1990-09-04
ATA249588A (de) 1993-06-15
ES2017838A6 (es) 1991-03-01
KR910007970B1 (ko) 1991-10-05
AT397088B (de) 1994-01-25
ES2017836A6 (es) 1991-03-01
FI884626A0 (fi) 1988-10-07
CH679397A5 (nl) 1992-02-14
FR2621585B1 (fr) 1994-01-28
KR890006610A (ko) 1989-06-14
GB8823567D0 (en) 1988-11-16
JPH0753725B2 (ja) 1995-06-07
ES2017837A6 (es) 1991-03-01
NL8802464A (nl) 1989-05-01
FI98460C (fi) 1997-06-25
ES2018111A6 (es) 1991-03-16
CA1320959C (en) 1993-08-03
DE3834204A1 (de) 1989-04-20
GB2210879B (en) 1991-09-18
GB2210879A (en) 1989-06-21

Similar Documents

Publication Publication Date Title
NL194914B (nl) 4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat.
NL190160B (nl) Piperazinecarboxamide- en -carbothioamidederivaten, werkwijze ter bereiding daarvan, alsmede farmaceutisch preparaat dat een dergelijk derivaat omvat.
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
HU905839D0 (en) Herbicide preparative containing isoxasole derivative and process for producing the active substance
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
MC1476A1 (fr) Derives de la pyrrolidine
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
DE69132578D1 (de) Cephemderivate
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose
SE8801945D0 (sv) New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
NO177707C (no) Fremgangsmåte for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksyd-(1R,2R)
NO820180L (no) Basisk substituert antranilsyrer, fremgangsmaate til deres fremstilling og deres anvendelse
IL64210A0 (en) 5-phenyltetrazoles containing basic substituents,a process for their preparation and their use as drugs
JPS53108936A (en) Epolysuccinic monoester derivative
SE8903313D0 (sv) New 2-methoxycarbonyl substituted n,n'-di(trimethoxybenzol) piperazines, process for preparing the same and therapeutical compounds compounds containing
SE7907656L (sv) 3,4-dihydroxikanelaldehydderivat
HUP9900736A2 (hu) Fluor-metoxi-akrilsav-származékok és kártevőirtó szerként történő alkalmazásuk
FR2401923A1 (fr) Nouvelles octahydropyrazinopyrimidinones 2,3,4,7,8,9-substituees, procede de preparation de ces derives et leur application en tant que medicaments
TH6975A (th) การใช้ไอซอกซาโซลิโนนเป็นยาที่ว่องไวต่อสมอง

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20081007